DE68926746T2 - Auf phosphozucker basierende antientzündliche und/oder immunitätsunterdrückende arzneimittel - Google Patents

Auf phosphozucker basierende antientzündliche und/oder immunitätsunterdrückende arzneimittel

Info

Publication number
DE68926746T2
DE68926746T2 DE68926746T DE68926746T DE68926746T2 DE 68926746 T2 DE68926746 T2 DE 68926746T2 DE 68926746 T DE68926746 T DE 68926746T DE 68926746 T DE68926746 T DE 68926746T DE 68926746 T2 DE68926746 T2 DE 68926746T2
Authority
DE
Germany
Prior art keywords
flammable
immunity
medicinal products
based medicinal
suppressing medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68926746T
Other languages
English (en)
Other versions
DE68926746D1 (de
Inventor
Christopher Parish
William Cowden
David Willenborg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Australian National University
Original Assignee
Australian National University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Australian National University filed Critical Australian National University
Publication of DE68926746D1 publication Critical patent/DE68926746D1/de
Application granted granted Critical
Publication of DE68926746T2 publication Critical patent/DE68926746T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04—Phosphates; Phosphites; Polyphosphates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE68926746T 1988-08-19 1989-08-18 Auf phosphozucker basierende antientzündliche und/oder immunitätsunterdrückende arzneimittel Expired - Lifetime DE68926746T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPI994288 1988-08-19
PCT/AU1989/000350 WO1990001938A1 (en) 1988-08-19 1989-08-18 Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs

Publications (2)

Publication Number Publication Date
DE68926746D1 DE68926746D1 (de) 1996-08-01
DE68926746T2 true DE68926746T2 (de) 1996-11-28

Family

ID=3773299

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68926746T Expired - Lifetime DE68926746T2 (de) 1988-08-19 1989-08-18 Auf phosphozucker basierende antientzündliche und/oder immunitätsunterdrückende arzneimittel

Country Status (4)

Country Link
EP (1) EP0429522B1 (de)
AT (1) ATE139699T1 (de)
DE (1) DE68926746T2 (de)
WO (1) WO1990001938A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308838A (en) * 1982-05-07 1994-05-03 Carrington Laboratories, Inc. Uses of aloe products
US5646123A (en) * 1991-06-10 1997-07-08 Alberta Research Council Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen
GB2299025B (en) * 1992-03-17 1996-11-27 British Tech Group Dispenser containing a formulation of mannose phosphate useful in the treatment of fibrotic disorders of the eye
GB9205800D0 (en) * 1992-03-17 1992-04-29 British Tech Group Treatment of fibrotic disorders
US5747461A (en) * 1994-07-26 1998-05-05 Markov; Angel K. Synergistic administration of cyclosporine and fructose diphosphate
SE9403137D0 (sv) 1994-09-20 1994-09-20 Perstorp Ab Derivatives of carbohydrates and compositions containing them
GB9516012D0 (en) * 1995-08-04 1995-10-04 Univ Manchester Pharmaceutical composition
US6566339B1 (en) 1995-08-04 2003-05-20 Renovo Limited Pharmaceutical composition
US6093388A (en) * 1996-08-12 2000-07-25 Btg International Limited Mannose-6-phosphate composition and its use in treating fibrotic disorders
AUPO309896A0 (en) 1996-10-18 1996-11-14 Australian National University, The Novel phosphosugars and phosphosugar-containing compounds having anti-inflammatory activity
AU2004299992B2 (en) 2003-12-18 2011-03-24 Procognia Ltd. Method for analyzing a glycomolecule
US7276486B2 (en) 2004-03-15 2007-10-02 Kimberly-Clark Worldwide, Inc. Compositions for vaginal treatment

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE334250C (de) * 1918-05-11 1921-03-14 Farbenfab Vorm Bayer F & Co Verfahren zur Darstellung von Fruktosemonophosphorsaeure
US4122179A (en) * 1976-06-03 1978-10-24 Enrico Corvi Mora Acid addition salts of vincamine and apovincamine
IT1143956B (it) * 1980-03-12 1986-10-29 Foscama Biomed Chim Farma Preparato di fruttosio-1,6-difosfato ad azione protettiva della membrana degli eritrociti in pazienti sottoposti a circolazione extracorporea
JPS58121216A (ja) * 1982-01-13 1983-07-19 Grelan Pharmaceut Co Ltd リン含有マンナン
IT1164363B (it) * 1983-08-03 1987-04-08 Foscama Biomed Chim Farma Procedimento terapeutico facente uso di liposomi imcorporati fruttosio 1,6 difosfato e procedimento per la preparazione degli stessi
IT1209519B (it) * 1984-04-10 1989-08-30 Poli Ind Chimica Spa Composti ad attivita'cardiotrofica.
ES541277A0 (es) * 1985-03-15 1985-12-16 Vinas Lab Procedimiento para la preparacion de un nuevo derivado de lafructosa
US4703040A (en) * 1985-04-03 1987-10-27 Markov Angel K Treatment of adult respiratory distress syndrome (ARDS) using fructose diphosphate (FDP)
HU199494B (en) * 1985-06-28 1990-02-28 Sandoz Ag Process for producing new saccharides and pharmaceutical compositions comprising same
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
DE3731953A1 (de) * 1987-09-23 1989-04-06 Sandoz Ag Neue saccharide, verfahren zu ihrer herstellung und ihre verwendung
IT1204764B (it) * 1986-01-17 1989-03-10 Foscama Biomed Chim Farma Utilizzazione terapeutica del fruttosio-1,6-difosfato per la protezione nei confronti della tossicita' indotta da somministrazione di antitumorali antraciclinici
JPH06702B2 (ja) * 1986-11-05 1994-01-05 花王株式会社 抗アレルギ−剤

Also Published As

Publication number Publication date
ATE139699T1 (de) 1996-07-15
WO1990001938A1 (en) 1990-03-08
EP0429522A4 (en) 1991-09-11
EP0429522B1 (de) 1996-06-26
EP0429522A1 (de) 1991-06-05
DE68926746D1 (de) 1996-08-01

Similar Documents

Publication Publication Date Title
ATE158182T1 (de) Arzneimittel sowie deren herstellung und deren verwendung bei der bekämpfung von schmerzen und/oder entzündungen an tieren und menschen
DE3382641D1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
IS3644A7 (is) Aðferð til að framleiða lyfjablöndu á formi smápilla til að meðhöndla þarmabólgur
NO306377B1 (no) Doseform for avgivelse av et medikament
DE68926746T2 (de) Auf phosphozucker basierende antientzündliche und/oder immunitätsunterdrückende arzneimittel
RU92016463A (ru) Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
DE69200711D1 (de) Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung.
DK561089A (da) Anvendelse af lactamimider til fremstilling af laegemidler
DK0559145T3 (da) Lægemiddel til truende abort
AU4058789A (en) Medicinal drug, method of treatment of human diseases therewith, and method and device for producing and preserving thereof
SE9000207D0 (sv) Laekemedel samt anvaendningen av detsamma
KR900009029A (ko) 가축병 치료용 약물을 투여하는 장치
EP0456842A4 (en) Medicinal application of m-csf
SE8105500L (sv) Psykotropa lekemedel
AU2366388A (en) A method for the preparation of a pharmaceutical curative for the veterinary and humane medicine, with antiviral and antitumoral effect
IT8848016A0 (it) Dispositivo elettro-medicale eprocedimento per la cura del dolore da nevralgie, malattie reumatiche, chirurgiche ed altre affezioni
FR2583755B1 (fr) Derives de 10 a-methoxy-6-methyl-ergoline, leur preparation et leur application en tant que medicament
UA30143A (uk) Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань
NO881870D0 (no) Doseringsenhet for hudoverfoeringsabsorbsjon av narkotiske analgesiske og antagonistiske stoffer og fremgangsmaate for administrering av samme.
IT7828549A0 (it) Composizione terapeutica per il trattamento di infezioni e malattie di animali da allevamento.
IT7827960A0 (it) Apparecchio fisioterapico a circolazione d'aria per la cura di piaghe, ferite ed affezioni cutanee che traggono beneficio dalla terapia con aria.
BG51774A1 (en) Pharmaceutical formulation basedon 4-hydroxy-2-methyl-2h-1,2-benzothiazine-3-/n-2-pyridylcarboxamide/ -1,1-dioxide
RU93001041A (ru) Способ лечения больных затяжной пневмонией
ATE59776T1 (de) Pharmazeutische zusammensetzung und behandlung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition